162 related articles for article (PubMed ID: 9787980)
1. Role of epidermal growth factor (EGF) in oesophageal mucosal integrity.
Marcinkiewicz M; Grabowska SZ; Czyzewska E
Curr Med Res Opin; 1998; 14(3):145-53. PubMed ID: 9787980
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of oesophageal mucosal defence.
Sarosiek J; McCallum RW
Baillieres Best Pract Res Clin Gastroenterol; 2000 Oct; 14(5):701-17. PubMed ID: 11003804
[TBL] [Abstract][Full Text] [Related]
3. Oesophageal defence mechanisms.
Hopwood D
Digestion; 1995; 56 Suppl 1():5-8. PubMed ID: 7556971
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor in the oesophagus.
Jankowski J; Coghill G; Tregaskis B; Hopwood D; Wormsley KG
Gut; 1992 Nov; 33(11):1448-53. PubMed ID: 1452065
[TBL] [Abstract][Full Text] [Related]
5. Do salivary organic components play a protective role in health and disease of the esophageal mucosa?
Sarosiek J; McCallum RW
Digestion; 1995; 56 Suppl 1():32-7. PubMed ID: 7556968
[TBL] [Abstract][Full Text] [Related]
6. The roles of excessive gastro-oesophageal reflux, disordered oesophageal motility and decreased mucosal sensitivity in the pathogenesis of Barrett's oesophagus.
Niemantsverdriet EC; Timmer R; Breumelhof R; Smout AJ
Eur J Gastroenterol Hepatol; 1997 May; 9(5):515-9. PubMed ID: 9187887
[TBL] [Abstract][Full Text] [Related]
7. Role of salivary epidermal growth factor in the pathogenesis of Barrett's columnar lined oesophagus.
Gray MR; Donnelly RJ; Kingsnorth AN
Br J Surg; 1991 Dec; 78(12):1461-6. PubMed ID: 1773326
[TBL] [Abstract][Full Text] [Related]
8. Diminished luminal release of esophageal epidermal growth factor in patients with reflux esophagitis.
Rourk RM; Namiot Z; Edmunds MC; Sarosiek J; Yu Z; McCallum RW
Am J Gastroenterol; 1994 Aug; 89(8):1177-84. PubMed ID: 8053431
[TBL] [Abstract][Full Text] [Related]
9. Measurement of bicarbonate output from the intact human oesophagus.
Brown CM; Snowdon CF; Slee B; Sandle LN; Rees WD
Gut; 1993 Jul; 34(7):872-80. PubMed ID: 8344572
[TBL] [Abstract][Full Text] [Related]
10. The association of gastric leptin with oesophageal inflammation and metaplasia.
Francois F; Roper J; Goodman AJ; Pei Z; Ghumman M; Mourad M; de Perez AZ; Perez-Perez GI; Tseng CH; Blaser MJ
Gut; 2008 Jan; 57(1):16-24. PubMed ID: 17761783
[TBL] [Abstract][Full Text] [Related]
11. A distinct salivary secretory response mediated by the esophago-salivary reflex in patients with Barrett's esophagus: its potential pathogenetic implications.
Yandrapu H; Marcinkiewicz M; Poplawski C; Namiot Z; Zbroch T; Sarosiek J
Adv Med Sci; 2014 Sep; 59(2):281-7. PubMed ID: 25181642
[TBL] [Abstract][Full Text] [Related]
12. Correlation of oesophageal acid exposure with Barrett's oesophagus length.
Fass R; Hell RW; Garewal HS; Martinez P; Pulliam G; Wendel C; Sampliner RE
Gut; 2001 Mar; 48(3):310-3. PubMed ID: 11171818
[TBL] [Abstract][Full Text] [Related]
13. Salivary and gastric epidermal growth factor in patients with Zollinger-Ellison syndrome: its protective potential.
Sarosiek J; Jensen RT; Maton PN; Peura DA; Harlow D; Feng T; McCallum RW; Pisegna JR
Am J Gastroenterol; 2000 May; 95(5):1158-65. PubMed ID: 10811321
[TBL] [Abstract][Full Text] [Related]
14. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
15. Review article: factors protecting the oesophagus against acid-mediated injury.
Brown CM; Rees WD
Aliment Pharmacol Ther; 1995 Jun; 9(3):251-62. PubMed ID: 7654887
[TBL] [Abstract][Full Text] [Related]
16. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus.
Koek GH; Sifrim D; Lerut T; Janssens J; Tack J
Gut; 2008 Aug; 57(8):1056-64. PubMed ID: 18403496
[TBL] [Abstract][Full Text] [Related]
17. [Quantification of gastro-esophageal reflux in Barrett's esophagus].
Ortiz Escandell A; Martínez de Haro LF; Parrilla Paricio P; Molina Martínez J; Aguayo Albasini JL; Martínez Gómez D
Rev Esp Enferm Dig; 1990 Mar; 77(3):171-5. PubMed ID: 2378753
[TBL] [Abstract][Full Text] [Related]
18. Acid suppression in the long-term treatment of peptic stricture and Barrett's oesophagus.
Lundell L
Digestion; 1992; 51 Suppl 1():49-58. PubMed ID: 1356869
[TBL] [Abstract][Full Text] [Related]
19. What role do salivary inorganic components play in health and disease of the esophageal mucosa?
Sarosiek J; McCallum RW
Digestion; 1995; 56 Suppl 1():24-31. PubMed ID: 7556967
[TBL] [Abstract][Full Text] [Related]
20. Barrett's oesophagus.
Navaratnam RM; Winslet MC
Postgrad Med J; 1998 Nov; 74(877):653-7. PubMed ID: 10197195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
